NanoVibronix to present positive UroShield study at ICS 2023; reduces CAUTI and blockages

ENvue Medical, Inc.

Dr. Sandra Wilks to present UroShield study at ICS 2023 in Toronto on September 27.
University of Southampton study shows UroShield reduces catheter-associated urinary tract infections and blockages.
Study suggests UroShield may promote healthy urinary microbiome and reduce antibiotic use.
UroShield uses low-frequency ultrasound to prevent bacterial biofilm on catheters.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.